- Home
- NBTX vs PDFS Comparison
NBTX vs PDFS Comparison
Compare NBTX & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- PDFS
- Stock Information
- Founded
- NBTX 2003
- PDFS 1992
- Country
- NBTX France
- PDFS United States
- Employees
- NBTX N/A
- PDFS N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- PDFS EDP Services
- Sector
- NBTX Health Care
- PDFS Technology
- Exchange
- NBTX Nasdaq
- PDFS Nasdaq
- Market Cap
- NBTX 1.3B
- PDFS 1.0B
- IPO Year
- NBTX 2020
- PDFS N/A
- Fundamental
- Price
- NBTX $21.69
- PDFS $23.93
- Analyst Decision
- NBTX Strong Buy
- PDFS Strong Buy
- Analyst Count
- NBTX 1
- PDFS 3
- Target Price
- NBTX $8.00
- PDFS $34.00
- AVG Volume (30 Days)
- NBTX 99.0K
- PDFS 262.0K
- Earning Date
- NBTX 09-30-2025
- PDFS 11-06-2025
- Dividend Yield
- NBTX N/A
- PDFS N/A
- EPS Growth
- NBTX N/A
- PDFS N/A
- EPS
- NBTX N/A
- PDFS N/A
- Revenue
- NBTX $11,930,711.00
- PDFS $206,706,000.00
- Revenue This Year
- NBTX N/A
- PDFS $23.72
- Revenue Next Year
- NBTX $122.94
- PDFS $18.44
- P/E Ratio
- NBTX N/A
- PDFS N/A
- Revenue Growth
- NBTX N/A
- PDFS 21.23
- 52 Week Low
- NBTX $2.76
- PDFS $15.91
- 52 Week High
- NBTX $30.35
- PDFS $32.37
- Technical
- Relative Strength Index (RSI)
- NBTX 53.91
- PDFS 33.00
- Support Level
- NBTX $19.90
- PDFS $24.20
- Resistance Level
- NBTX $23.56
- PDFS $25.25
- Average True Range (ATR)
- NBTX 1.39
- PDFS 1.09
- MACD
- NBTX 0.06
- PDFS -0.59
- Stochastic Oscillator
- NBTX 69.36
- PDFS 7.53
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About PDFS PDF Solutions Inc.
PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.